Safety and efficacy of the ultra-rush immunotherapy with extracts of Dermatophagoides pteronyssinus in children |
Hyun, Sei Eun
(Department of Pediatrics, College of Medicine, Pochon CHA University)
Kim, Hyoung Yun (Department of Pediatrics, College of Medicine, Pochon CHA University) Kwak, Ji Hee (Department of Pediatrics, College of Medicine, Pochon CHA University) Shin, Youn Ho (Department of Pediatrics, College of Medicine, Pochon CHA University) Seo, Ji Yeong (Department of Pediatrics, College of Medicine, Pochon CHA University) Han, Man Yong (Department of Pediatrics, College of Medicine, Pochon CHA University) |
1 | Joint Task Force on Practice Parameters. Allergen immunotherapy: A practice parameter. american academy of allergy, asthma and immunology. american college of allergy, asthma and immunology. Ann Allergy Asthma Immunol 2003;90(1 Suppl):1S-40S |
2 | Schiavino D, Nucera E, Pollastrini E, De Pasquale T, Buonomo A, Bartolozzi F, et al. Specific ultrarush desensitization in hymenoptera venom-allergic patients. Ann Allergy Asthma Immunol 2004;92:409-13 DOI ScienceOn |
3 | Birnbaum J. Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): A safety and risk factors. Clin Exp Allergy 2003;33:58-64 DOI |
4 | Nagata M, Yamamoto H, Tabe K, Kimura I, Houya I, Kuramitsu K, et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: Changes in in vivo and in vitro responses to HDM. Intern Med 1993;32:702-9 DOI |
5 | Boquete M, Carballada F, Exposito F, Gonzalez A. Preventive immunotherapy. Allergol Immunopathol (Madr) 2000;28:89-93 |
6 | Le Roux P, Le Luyer B. Accelerated desensitization to dermatophagoides pteronyssinus mites in children with asthma. results of two years of immunotherapy. Allerg Immunol (Paris) 1991;23:135-42 |
7 | Akmanlar N, Altintas DU, Guneser KS, Yilmaz M, Bingol G. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy. Allergol Immunopathol (Madr) 2000;28:213-8 |
8 | Paty E, de Blic J, Brunet D, Le Bourgeois M, Garcelon M, Paupe J, et al. Accelerated desensitization with dermatophagoides pteronyssinus in severe asthmatic children. evaluation after one year of immunotherapy. Arch Fr Pediatr 1990;47:173-9 |
9 | Hirokawa Y, Kondo T, Kobayashi I, Ohta Y. Rush immunotherapy with house dust extract in patients with mild extrinsic asthma. Tohoku J Exp Med 1996;178:371-80 DOI |
10 | Tabar AI, Echechipia S, Garcia BE, Olaguibel ]M, Lizaso MT, Gomez B, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with dermatop-hagoides pteronyssinus. J Allergy Clin Immunol 2005;116:109-18 DOI ScienceOn |
11 | Nanda A, O'connor M, Anand M, Dreskin SC, Zhang L, Hines B, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004;114:1339-44 DOI ScienceOn |
12 | Golden DB, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of hymenoptera venom immunotherapy. Ann Intern Med 1980;92:620-4 DOI ScienceOn |
13 | Kohno Y, Minoguchi K, Oda N, Yokoe T, Yamashita N, Sakane T, et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J Allergy Clin Immunol 1998;102(6 Pt 1):927-34 DOI ScienceOn |
14 | Sturm G, Kranke B, Rudolph C, Aberer W. Rush hyrnenoptera venom immunotherapy: A safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110:928-33 DOI ScienceOn |
15 | Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized dermatophagoides pteronyssinus extract. IV. systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473-9 DOI |
16 | Sharkey P, Portnoy J. Rush immunotherapy: Experience with a one-day schedule. Ann Allergy Asthma Immunol 1996;76:175-80 DOI ScienceOn |
17 | Casanovas M, Martin R, Jimenez C, Caballero R, Fernandez-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol 2006;139:153-8 DOI ScienceOn |
18 | Tabar AI, Fernandez-Tavora L, Alonso R, Castillo R, Cistero-Bahima A, de la Torre-Morin F, et al. Olerance of a cluster schedule with a house dust mite extract quantified in mass units: Multicentre study. J Investig Allergol Clin Immunol 2004;14:193-7 |
19 | Lockey RF, Nicoara-Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(1 Suppl):47S-55S DOI |
20 | Ibero M, Castillo MJ Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol 2006;16:194-202 |
21 | Scribner TA, Bernstein DI. Rapid venom immunotherapy update. Curr Opin Allergy Clin Immunol 2003;3:295-8 DOI ScienceOn |
22 | Birnbaum J. Ramadour M, Magnan A, Vervloet D. Hymenoptera ultra-rush venom immunotherapy (210 min): A safety study and risk factors. Clin Exp Allergy 2003;33:58-64 DOI |
23 | van der Brempt X, Ledent C, Mairesse M. Accelerated desensitization for hymenoptera venom allergy in 30 hours: Efficacy and safety in 150 cases. Rev Med Brux 1997;18:120-4 |
24 | Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;4:CD001186 |
25 | Litvyakova LI, Baraniuk JN. Nasal provocation testing: A review. Ann Allergy Asthma Immunol 2001;86:355-64 DOI ScienceOn |
26 | Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. J Investig Allergol Clin Immunol 2006;16:79-85 |